Notify me when James N. Topper files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PHAT | PHATHOM PHARMACEUTICALS, INC. | Common Stock, $0.0001 par value per share | 8.6% | $70.4M | 5.99M | 0% | James N. Topper | Nov 1, 2025 | |
| MIRM | MIRUM PHARMACEUTICALS, INC. | Common Stock, par value $0.0001 per share | 7.4% | $274M | 3.74M | 0% | James N. Topper | Nov 1, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|